Drug Information

Drug General Information
Drug ID
D07YQY
Former ID
DNC013770
Drug Name
N-benzylnorlitebamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534555]
Structure
Download
2D MOL

3D MOL
Formula
C26H25NO4
Canonical SMILES
COC1=C(C=C2C=CC3=C(C2=C1)C(=C(C4=C3CCN(C4)CC5=CC=CC=C5)<br />O)OC)O
InChI
1S/C26H25NO4/c1-30-23-13-20-17(12-22(23)28)8-9-19-18-10-11-27(14-16-6-4-3-5-7-16)15-21(18)25(29)26(31-2)24(19)20/h3-9,12-13,28-29H,10-11,14-15H2,1-2H3
InChIKey
ITXWZNATGXDCEV-UHFFFAOYSA-N
PubChem Compound ID
10597941
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [534555]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 534555J Nat Prod. 1998 Jan;61(1):46-50.Litebamine N-homologues: preparation and anti-acetylcholinesterase activity.
Ref 534555J Nat Prod. 1998 Jan;61(1):46-50.Litebamine N-homologues: preparation and anti-acetylcholinesterase activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.